Market Forecast by Countries (United States, Canada), By Type (Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines), By Disease (Porcine, Poultry, Livestock, Companion Animal, Aquaculture), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines) And Competitive Landscape
Product Code: ETC075420 | Publication Date: Aug 2021 | Updated Date: Aug 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 | |
Report Name | North America Veterinary Vaccines Market |
Forecast period | 2024-2030 |
CAGR | 5.8% |
Growing Sector | Veterinary Healthcare |
North America Veterinary Vaccines Market report thoroughly covers the market by countries, type, disease and technology. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
North America Veterinary Vaccines Market is experiencing significant growth and projected to attain more growth in the coming years due to the increasing prevalence of zoonotic diseases and the rising awareness of animal health. This market encompasses a wide range of vaccines designed to prevent diseases in animals, including livestock, companion animals, and poultry. Factors such as advancements in vaccine technology, government initiatives promoting animal health, and the expanding livestock population are fuelling the demand for veterinary vaccines in the region.
According to 6Wresearch, North America Veterinary Vaccines Market size is expected to grow at a CAGR of 5.8% during 2024-2030. Several factors are driving the growth of North America Veterinary Vaccines Market such as the rising incidence of zoonotic diseases, which pose significant threats to both animal and human health, underscores the need for effective vaccination programs. As public awareness about the importance of animal health increases, pet owners and livestock farmers are more inclined to invest in preventive measures, including vaccinations. Additionally, government initiatives and funding aimed at controlling disease outbreaks in animals are further stimulating market growth. Advances in biotechnology have also led to the development of novel and more effective veterinary vaccines, enhancing their adoption.
However, North America Veterinary Vaccines Market faces few restraints such as the high cost associated with the development and production of advanced vaccines. These costs can limit access for smaller veterinary practices and livestock farmers, potentially hampering market expansion. Additionally, stringent regulatory frameworks and the lengthy approval process for new vaccines can delay the introduction of innovative products to the market. There is also a degree of vaccine hesitancy among some pet owners and farmers, stemming from a lack of education about their benefits and misconceptions about potential side effects.
The key players include Zoetis Inc, Merck & Co, Boehringer Ingelheim International, Elanco Animal Health Incorporated, Ceva Santé Animale, Hester Biosciences Limited. These companies focus on preventive care for animals, delivering vaccines that address numerous animal health issues, supported by extensive research initiatives.
North America Veterinary Vaccines Market is growing and government’s regulation and policies are helping in extension of the market. U.S. Department of Agriculture (USDA) runs several programs focused on disease monitoring, research, and prevention, including funding for vaccine development and distribution. These initiatives help ensure the availability of effective vaccines and promote vaccination campaigns among livestock farmers and pet owners. Furthermore, collaborations between governmental bodies and private companies accelerate the commercialization of innovative veterinary vaccines by facilitating funding and streamlining regulatory hurdles.
The future of North America Veterinary Vaccines Market looks promising due to various factors such as the integration of artificial intelligence and machine learning, are expected to revolutionize vaccine development and disease detection, enabling quicker and more precise responses to emerging health threats in animals. Personalized veterinary medicine is also gaining traction, with vaccines tailored to the specific needs of individual animals or groups, enhancing the efficacy and safety of vaccinations. Additionally, the growing concern over zoonotic diseases and the one-health approach, which recognizes the interconnected health of people, animals, and the environment, will likely propel further investment into veterinary vaccines research and development.
According to Ravi Bhandari, Research Head, 6Wresearch, United States is expected to experience robust growth in coming years attributed to significant investments in veterinary research and development. The presence of numerous leading animal healthcare companies headquartered in the U.S.
Companion animal vaccine market is anticipated to grow the most in the future due to the burgeoning pet population and the increasing humanization of pets. Pet owners are becoming more proactive in ensuring their animals' health.
Companion animal diseases are projected to grow the most in the future attributed to continuous rise in pet ownership, coupled with growing trends in pet humanization and advancements in vaccine technology, underscores the robust demand in this market.
Recombinant vaccines are projected to grow the most in the future due to their versatility, safety profile, and the advent of cutting-edge genetic vaccine technologies, such as DNA and mRNA vaccines.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Veterinary Vaccines Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Veterinary Vaccines Market Revenues & Volume, 2020 & 2030F |
3.3 North America Veterinary Vaccines Market - Industry Life Cycle |
3.4 North America Veterinary Vaccines Market - Porter's Five Forces |
3.5 North America Veterinary Vaccines Market Revenues & Volume Share, By Countries, 2020 & 2030F |
3.6 North America Veterinary Vaccines Market Revenues & Volume Share, By Type, 2020 & 2030F |
3.7 North America Veterinary Vaccines Market Revenues & Volume Share, By Disease, 2020 & 2030F |
3.8 North America Veterinary Vaccines Market Revenues & Volume Share, By Technology, 2020 & 2030F |
4 North America Veterinary Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Veterinary Vaccines Market Trends |
6 North America Veterinary Vaccines Market, 2020 - 2030 |
6.1 North America Veterinary Vaccines Market, Revenues & Volume, By Type, 2020 - 2030 |
6.2 North America Veterinary Vaccines Market, Revenues & Volume, By Disease, 2020 - 2030 |
6.3 North America Veterinary Vaccines Market, Revenues & Volume, By Technology, 2020 - 2030 |
7 United States Veterinary Vaccines Market, 2020 - 2030 |
7.1 United States Veterinary Vaccines Market, Revenues & Volume, By Type, 2020 - 2030 |
7.2 United States Veterinary Vaccines Market, Revenues & Volume, By Disease, 2020 - 2030 |
7.3 United States Veterinary Vaccines Market, Revenues & Volume, By Technology, 2020 - 2030 |
8 Canada Veterinary Vaccines Market, 2020 - 2030 |
8.1 Canada Veterinary Vaccines Market, Revenues & Volume, By Type, 2020 - 2030 |
8.2 Canada Veterinary Vaccines Market, Revenues & Volume, By Disease, 2020 - 2030 |
8.3 Canada Veterinary Vaccines Market, Revenues & Volume, By Technology, 2020 - 2030 |
9 North America Veterinary Vaccines Market Key Performance Indicators |
10 North America Veterinary Vaccines Market - Opportunity Assessment |
10.1 North America Veterinary Vaccines Market Opportunity Assessment, By Countries, 2020 & 2030F |
10.2 North America Veterinary Vaccines Market Opportunity Assessment, By Type, 2020 & 2030F |
10.3 North America Veterinary Vaccines Market Opportunity Assessment, By Disease, 2020 & 2030F |
10.4 North America Veterinary Vaccines Market Opportunity Assessment, By Technology, 2020 & 2030F |
11 North America Veterinary Vaccines Market - Competitive Landscape |
11.1 North America Veterinary Vaccines Market Revenue Share, By Companies, 2023 |
11.2 North America Veterinary Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Company Profiles |
13 Recommendations |
14 Disclaimer |